![]() |
Mutation Database Mutations of the Retinal Guanylate Cyclase Gene and the Retinal Guanylate Cyclase-activating Protein Gene |
Recent update from: 11.04.2006
| Phenotype | Mutation | Basechange | Nucleotide | Exon | Restriction Site | Classification & Remarks |
Mutation Database | OMIM | Reference |
|---|---|---|---|---|---|---|---|---|---|
| Mutation map |
|
|
Map | ||||||
| Sequence | Italics: Mutation can be tested by a LCA-Microarray |
The sequence data are adjusted to a sequence given in a WORD file which can be downloaded here. Nucleotides are counted from the translation start site as recommended by HGVS. |
|||||||
| LCA | -24delG | GGA CTT>G_A CTT | c.-0024 | 5' UTR |
Homozygous Compound:
|
(3)
(5) |
|||
| Microarray | Met 1 Lys | ATG>AAG | c.0002 | 02 |
|
||||
| CORD | Met 1 Ile | ATG>ATA | c.0003 | 02 |
Activity reduced Benin Compound:
Patients: 11 |
goto HGMD |
(28)
(26) |
||
| CORD | Met 1 Ile | ATG>ATC | c.0003 | 02 |
Activity reduced French Compound:
Patients: 51 |
goto HGMD | (26) | ||
| CORD | 52dup48bp | GGT CCC GCG TGG TGG GCT CCG TCC CTG CCC CGC CTC CCC CGG GCC CTG | c.0052 | 02 |
Tunesian
Patients: 85 |
goto HGMD | (26) | ||
| Polymorphism | Trp 21 Arg | TGG/CGG | c.0061 | 02 |
Activity normal |
(28) | |||
| Microarray | 87insC | CTC CCC CGG>CTC CCC CCG G | c.0087 | 02 |
|
||||
| CORD? | Leu 41 Phe | CTC>TTC | c.0121 | 02 |
Activity normal Tunisian Compound:
Patients: 89 |
goto HGMD |
(28)
(26) |
||
| Polymorphism | Ala 52 Ser | GCT/TCT | c.0154 | 02 |
|
600179-0004 | (25) | ||
| CORD | 226del14bp | CTG GCC GCC CGC CTG GCC GCC>CTG ___ ___ ___ ___ __C GCC | c.0226 | 02 |
Antillas
Patients: 110 |
goto HGMD | (26) | ||
| Microarray | Glu 97 Gln | GAG>CAG | c.0289 | 02 |
|
||||
| Microarray | Glu 103 Lys | GAG>AAG | c.0307 | 02 |
|
||||
| LCA | Cys 105 Tyr | TGC>TAC | c.0314 | 02 |
Reduced activity No total loss of function Compound:
|
goto HGMD |
(5)
(16) (32) |
||
| CORD | 387delC | AAC CCT>AA_ CCT | c.0387 | 02 | -SmaI |
Patients: 3 90 91 118 |
goto HGMD | 600179-0002 |
(25)
(26) |
| CORD | Asn 129 Lys | AAC>AAA | c.0387 | 02 |
Activity normal Italian Compound
Patients: 82 |
goto HGMD |
(28)
(26) |
||
| CORD | 620delC | GCC CGG>GC_ CGG | c.0620 | 02 | +BspMI |
Patients: 23 34 |
goto HGMD | 600179-0003 |
(25)
(26) |
| Microarray | Leu 260 Pro | CTG>CCG | c.0779 | 3 |
|
||||
| LCA | Thr 312 Met | ACG>ATG | c.0935 | 03 |
Heterozygous Compound:
|
(9)
(8) |
|||
| CORD | Arg 313 Cys | CGC>TGC | c.0937 | 03 |
Activity normal Italian Compound
Patients: 52 |
goto HGMD |
(28)
(26) |
||
| LCA | Leu 325 Pro | CTG>CCG | c.0974 | 03 |
|
goto HGMD |
(16)
(32) (2) |
||
| Microarray | Tyr 351 Cys | TAT>TGT | c.1052 | 04 |
|
||||
| Microarray | Ala 362 Ser | GCA>TCA | c.1084 | 04 |
|
||||
| Polymorphism | Val 373 Val | GTC/GTA | c.1117 | 04 |
|
(19) | |||
| Polymorphism | Asp 412 Asp | GAC/GAT | c.1236 | 04 | +MboI |
|
(19) | ||
| CORD | Ser 448 ter | TCG>TAG | c.1343 | 04 |
Italian Compound
Patients: 52 |
goto HGMD | (26) | ||
| Polymorphism | IVS4-28a/g | cagta/cggta | c.1379 | IVS4 | -DdeI, +BfaI |
|
(4) | ||
| LCA | 1424-1431dup | GTC TCC GGC C>GTC TCC GGC CGTC TCC GGC C | c.1424 | 05 |
|
goto HGMD | (18) | ||
| Microarray | Leu 513 Phe | CTC>TTC | c.1537 | 06 |
|
||||
| Microarray | IVS6+2t>c | AAG gtggg>AAG gcggg | c.1566 | IVS06 |
|
||||
| LCA | Ile 539 Val | ATT>GTT | c.1615 | 07 |
Heterozygous Compound:
|
(29) | |||
| CORD | Arg 540 Cys | CGC>TGC | c.1618 | 07 |
Dutch Compound
Patients: 117 |
goto HGMD | (26) | ||
| LCA | Phe 565 Ser | TTC>TCC | c.1694 | 08 |
Homozygous Compound:
Patients: 441 22597 |
600179-0001 | (39) | ||
| CORD | Phe 565 Ser | TTC>TCC | c.1694 | 08 |
Published as F589S Algeria Compound:
Patients: 7 17 36 |
600179-0001 |
(25)
(26) |
||
| LCA | Ile 573 Val | ATC>GTC | c.1717 | 08 |
|
goto HGMD | (5) | ||
| LCA | Pro 575 Leu | CCA>CTA | c.1724 | 07 |
Heterozygous Compound
|
(17) | |||
| CORD | 1806del25bp | GG GGA GCA GAA GGC CCT GCG GCC CT | c.1806 | 09 |
Previously reported as 1805del25bp
Patients: 20 |
goto HGMD | (26) | ||
| CORD | IVS9+2t>a | AAG gtgtg>AAG gagtg | c.1957 | IVS9 |
Previously reported as 1956+2t-a
Patients: 70 |
goto HGMD | (26) | ||
| CORD | IVS9-1g>t | caag GGA>caat GGA | c.1957 | IVS9 |
Previously reported as 1957-1g-t
Patients: 51 |
goto HGMD | (26) | ||
| CORD | IVS9-1g>a | caag GGA>caaa GGA | c.1957 | IVS9 |
Previously reported as 1957-1g-a
Patients: 88 |
goto HGMD | (26) | ||
| Microarray | Gly 653 Arg | GGA>AGA | c.1957 | 10 |
|
||||
| LCA | Arg 660 ter | CGA>TGA | c.1978 | 10 |
Published as R684X |
goto HGMD |
(31)
(18) |
||
| LCA | Arg 660 Gln | CGA>CAA | c.1979 | 10 |
Published as R684Q |
goto HGMD | (18) | ||
| Microarray | 2078del8bp | GAA GCA CAG AAG GTG>GAA G__ ___ ___ GTG | c.2078 | 10 |
|
||||
| Microarray | Glu 694 Lys | CAG>AAG | c.2080 | 10 |
|
||||
| ARRP | Pro 701 Ser | CCC>TCC | c.2101 | 10 | -ScrFI |
Compound
Patients: 25855 8432 |
goto HGMD | (1) | |
| LCA | Pro 701 Ser | CCC>TCC | c.2101 | 10 | -ScrFI |
|
goto HGMD | (5) | |
| Polymorphism | Ala 703 Ala | GCG/GCA | c.2109 | 10 | -BsrBI |
|
(19) | ||
| LCA | Tyr 746 Cys | TAT>TGT | c.2237 | 11 |
Homozygous Published as Y770C |
goto HGMD | (18) | ||
| Microarray | Glu 750 ter | GAG>TAG | c.2248 | 11 |
|
||||
| LCA | Arg 768 Trp | CGG>TGG | c.2302 | 12 |
Published as R792W Homozygous Compound:
Patients: 441 20955 21067 21557 22018 26669 |
goto HGMD |
(18)
(39) (1) |
||
| LCA | Met 773 Leu | ATG>CTG | c.2317 | 12 |
Published as M797L |
goto HGMD | (18) | ||
| Rare Variant | Leu 782 His | CTC>CTA | c.2345 | 12 |
|
(19) | |||
| LCA | Arg 795 Leu | CGG>CTG | c.2384 | 12 |
Activity abolished |
(28) | |||
| CORD | Glu 837 Asp | GAG>GAC | c.2511 | 13 | -HhaI |
Little effect on activation by GCAP1 |
goto HGMD | 600179-0005 |
(37)
(14) |
| CORD6 = CORD5 | Arg 838 Cys | CGC>TGC | c.2512 | 13 | -HhaI |
Increased apparent affinity for activation by GCAP1 Reduced suppression by Ca2+/GCAP1 Constitutive activy even at high [Ca++] No rod degeneration in young patients Cone affection followed by rod affection |
goto HGMD | 600179-0006 |
(37)
(34) (33) (12) (15) 580.pdf>To online reference |
| CORD6/LCA | Arg 838 Ser | CGC>AGC | c.2512 | 13 | -HhaI |
Introduces additional coil to coiled-coil domain Reduced basal activity GCAP1 affinity increased allele in cis: E837D |
goto HGMD |
(10)
(35) (37) (23) |
|
| CORD | Arg 838 Ser - Arg 838 Ser - Thr 839 Met | GAG CGC ACG>GAC TGC ATG | c.2512 | 13 |
Complex rearrangement |
(27) | |||
| CORD | Arg 838 Ser - Arg 838 Ser | GAG CGC>GAC TGC | c.2512 | 13 |
Complex rearrangement |
goto HGMD | 600179-0005 | (10) | |
| CORD6 = CORD5 | Arg 838 His | CGC>CAC | c.2513 | 13 |
Maximum activity at pH 8.0 Basal activity slightly reduced GCAP1 affinity increased |
goto HGMD | 600179-0008 |
(37)
(33) (12) (23) 580.pdf>To online reference |
|
| CORD | Thr 839 Met | ACG>ATG | c.2516 | 13 |
|
goto HGMD | 600179-0007 | (27) | |
| LCA | Gln 855 ter | CAG>TAG | c.2564 | 13 |
|
goto HGMD | (7) | ||
| Microarray | Met 856 Val | ATG>GTG | c.2566 | 13 |
|
||||
| LCA | Pro 858 Ser | CCT>TCT | c.2572 | 13 |
|
goto HGMD |
(3)
(5) (16) (35) (32) |
||
| Polymorphism | IVS13+37g/t | agggc/atggc | c.2576 | IVS13 | -PvuII |
|
(19) | ||
| CORD | Ile 915 Thr | ATC>ATT | c.2745 | 14 |
On the same allele with G917R |
(12) | |||
| CORD | Gly 917 Arg | GGT>CGT | c.2749 | 14 |
On the same allele with I915T |
(12) | |||
| Microarray | Ala 934 Pro | GCC>CCC | c.2800 | 15 |
|
||||
| LCA | Ala 946 Val | GCG>GTG | c.2837 | 15 |
Compound
Patients: 21067 |
(39) | |||
| Microarray | Ala 950 Val | GCC>GTC | c.2849 | 15 |
|
||||
| LCA | Leu 954 Pro | CTG>CCG | c.2861 | 15 |
|
goto HGMD |
(3)
(5) (16) (17) (32) (9) (8) |
||
| LCA | 2899delC | CGC CAT ATG>CGC _AT ATG | c.2899 | 15 |
Published as del C in codon 991 |
goto HGMD | (18) | ||
| CORD | Arg 976 Leu | CGC>CTC | c.2927 | 14 |
Patients: 31 |
goto HGMD | (26) | ||
| LCA | 2943delG | CAC TCG G gtaac>CAC TC_ G gtaac | c.2943 | 15 |
Compound:
|
goto HGMD | 600179-0009 |
(11)
(9) (8) (24) 538 775.pdf>To online reference |
|
| Microarray | Cys 984 Tyr | TGC>TAC | c.2951 | 16 |
|
||||
| LCA | Arg 995 Trp | CGG>TGG | c.2983 | 16 |
Activity abolished Italian Compound
Patients: 82 |
goto HGMD |
(28)
(26) |
||
| CORD | Met 1009 Leu | ATG>TTG | c.3025 | 16 |
Activity abolished Belgium Compound
Patients: 88 |
goto HGMD |
(28)
(26) |
||
| CORD | IVS16+4a>t | tgag t>tgtg t | c.3043 | IVS16 |
Compound
|
(24) | |||
| CORD | His 1019 Pro | CAC>CCC | c.3055 | 17 |
Activity abolished Pakistan Compound:
Patients: 56 |
goto HGMD |
(28)
(26) |
||
| LCA | 3055del10bpins4bp | ATC CAC GTG AAC TTG>ATC ACA GTG | c.3055 | 17 |
Homozygous |
goto HGMD | (5) | ||
| CORD | 3078delGA | GTG GGG ATT CTC>GTG GG_ _TT CTC | c.3078 | 17 |
Patients: 33 |
goto HGMD | (26) | ||
| CORD | Gln 1036 ter | CAG>TAG | c.3106 | 17 |
French Compound
Patients: 72 |
goto HGMD | (26) | ||
| LCA | Gln 1036 His | CAG>CAT | c.3108 | 17 |
Activity abolished |
(28) | |||
| LCA | Arg 1040 Gly | CGA>GGA | c.3118 | 17 |
Homozygous published as R1064G Patients: ### |
goto HGMD | (18) | ||
| Microarray | Arg 1040 ter | CGA>TGA | c.3118 | 02 |
|
||||
| Polymorphism | IVS17+34g/t | ccccg/cccct | c.3138 | 17 | -MnlI |
|
(4) | ||
| Microarray | Gly 1061 Ser | GGC>AGC | c.3181 | 19 |
|
||||
| EOSRP | 3205delC | AAA CCG>AAA _CG | c.3205 | 18 |
Compound
Patients: 25556 |
(1) | |||
| EOSRP | 3236insACCA | AAC CAC GGC>AAC CAA CCA CGG C | c.3236 | 19 |
|
(24) | |||
| Polymorphism | Leu 1094 Leu | CTG/CTT | c.3280 | 19 | +BfaI |
|
(5) | ||
| Polymorphism | 3455c/t | gttct/gttct | c.3455 | 20 |
|
(19) |
| Phenotype | Mutation | Basechange | Nucleotide | Exon | Restriction Site | Classification & Remarks |
Mutation Database | OMIM | Reference |
|---|---|---|---|---|---|---|---|---|---|
| Sequence |
|
The mutation data for this gene are currently not adjusted to a standardised sequence and given as reported by the authors cited. |
|||||||
| ACHM | IVS3+171delg | g/_ | c. |
IVS3 |
Heterozygous Patients: 065-011 |
(21) | |||
| ACHM | -26a/g | a/g | c.-026 | 5' UTR |
Heterozygous Patients: 065-001 |
(21) | |||
| adCRD | Pro 50 Leu | c.150 | 2 |
Heterozygous |
(6) | ||||
| COD | Tyr 99 Cys | TAT>TGT | c.296 | 02 |
Altered Ca2+ sensitivity |
(38) | |||
| adCRD | Tyr 99 Cys | TAT>TGT | c.296 | 2 |
Heterozygous |
goto HGMD |
(22)
(6) (20) |
||
| Atypical RP | Thr 114 Ile | C>T | c.341 | 2 |
Heterozygous Patients: 199-005 |
(21) | |||
| adCRD | Ile 143 Asn-Thr | del T > ins ACAC | c.428 | 2 |
Heterozygous effecting the EF4-Ca++ binding site Mutation creates conformation susceptible for degradation Patients: 195-001 |
(21) | |||
| CORD6 | Leu 150 Phe | C>T | c.450 | 4 |
Heterozygous decreases CA++-sensitivity of RetGC1 persistent stimulation of RetGC1 in the dark gain of function mutation |
(30) | |||
| CORD6 | Leu 151 Phe | C>T | c.451 | 4 |
Conserved residue in vertebrate GCAPs |
(13) | |||
| CORD | Glu 155 Gly | c. |
4 |
|
(36) | ||||
| MD, ACHM | Asp 189 Asp | C>T | c.577 | 4 |
Heterozygous Patients: 111-007 270-03 |
(21) |
References
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
|
Return to Retina International‘s Scientific Newsletter |
Return to Mutation Database Page |
Return to pagehead |
Contact the editor |
Return to Database Page |
This site is maintained and edited by
Dr. rer. medic. Markus Preising, Dipl.Biol. Molecular Genetics Laboratory Department of Paediatric Ophthalmology, Strabismology and Ophthalmogenetics University of Regensburg Head: Prof. Dr. med. Birgit Lorenz |
|